Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review

Formalin-fixed, paraffin-embedded (FFPE) tissue epigenomics using Infinium HumanMethylation450 BeadChip assays

(2015) Tim C de Ruijter et al.   LABORATORY INVESTIGATION

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis

(2014) Y. Y. Juo et al.   ANNALS OF ONCOLOGY

Colorectal cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms

(2014) Zhujun Xiao et al.   CLINICA CHIMICA ACTA

CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer

(2014) A. H. G. Cleven et al.   CLINICAL CANCER RESEARCH

CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer

(2014) Stacey Shiovitz et al.   GASTROENTEROLOGY

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis

(2013) C. C. J. M. Simons et al.   ANNALS OF ONCOLOGY

Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision

(2013) Marisa Donada et al.   BMC GASTROENTEROLOGY

Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location

(2013) J M Bae et al.   BRITISH JOURNAL OF CANCER

Associations Between Colorectal Cancer Molecular Markers and Pathways With Clinicopathologic Features in Older Women

(2013) N.Jewel Samadder et al.   GASTROENTEROLOGY

Subsets of microsatellite-unstable colorectal cancers exhibit discordance between the CpG island methylator phenotype and MLH1 methylation status

(2013) Jung H Kim et al.   MODERN PATHOLOGY

Clinical Outcomes of Patients with Microsatellite-Unstable Colorectal Carcinomas Depend on L1 Methylation Level

(2012) Ye-Young Rhee et al.   ANNALS OF SURGICAL ONCOLOGY

Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer

(2012) Sae-Won Han et al.   INTERNATIONAL JOURNAL OF CANCER

Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma

(2012) Sanjay Kakar et al.   MODERN PATHOLOGY

Stratification and Prognostic Relevance of Jass’s Molecular Classification of Colorectal Cancer

(2012) Inti Zlobec et al.   Frontiers in Oncology

Distinct Profiles of Epigenetic Evolution between Colorectal Cancers with and without Metastasis

(2011) Hai-xing Ju et al.   AMERICAN JOURNAL OF PATHOLOGY

The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy

(2011) Byung-Hoon Min et al.   BMC CANCER

Divergent Oncogenic Changes Influence Survival Differences between Colon and Rectal Adenocarcinomas

(2011) Matthew F. Kalady et al.   DISEASES OF THE COLON & RECTUM

Genome-scale analysis of aberrant DNA methylation in colorectal cancer

(2011) T. Hinoue et al.   GENOME RESEARCH

Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor

(2011) Anna M Dahlin et al.   MODERN PATHOLOGY

CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer

(2011) Peter Jo et al.   SURGERY

Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status

(2011) Jeong Mo Bae et al.   VIRCHOWS ARCHIV

The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status

(2010) A. M. Dahlin et al.   CLINICAL CANCER RESEARCH

5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer

(2010) Rodrigo Jover et al.   GASTROENTEROLOGY

Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation

(2010) Sun Lee et al.   PATHOLOGY INTERNATIONAL

Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer

(2009) J. A. Sanchez et al.   BRITISH JOURNAL OF SURGERY

Microsatellite instability and survival in rectal cancer

(2009) Wade S. Samowitz et al.   CANCER CAUSES & CONTROL

Three DNA Methylation Epigenotypes in Human Colorectal Cancer

(2009) K. Yagi et al.   CLINICAL CANCER RESEARCH

Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers

(2009) Jung Ho Kim et al.   VIRCHOWS ARCHIV

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE

Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases

(2008) L. Barault et al.   CANCER RESEARCH

Mutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon Cancer

(2008) Takeshi Nagasaka et al.   GASTROENTEROLOGY

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

(2008) S. Ogino et al.   GUT